RISA Labs develops AI-powered workflow automation for oncology care. The company's core product, the BOSS Console platform, functions as an AI operating system designed to streamline administrative tasks in cancer treatment settings. It automates prior authorization, eligibility verification, claims status tracking, and denial management by employing multi-agent systems and digital twin architecture.
The company's technical domains include artificial intelligence, multi-agent systems, and digital twin architecture. RISA Labs primarily serves the healthcare operations sector, with its solutions targeted at oncology practices, cancer centers, infusion centers, specialty pharmacies, and health systems.
RISA Labs has a geographic presence in Palo Alto, California; the broader Bay Area; New York; Boston; and Bangalore. The company was founded by IIT Kanpur alumni with a background from a previous healthcare startup, Urban Health. It is backed by investors including Optum Ventures, Cencora Ventures, and General Catalyst.
